AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22009525 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin (CIP IV) 300 mg b.i.d. in upper gastrointestinal surgery patients.
Number of subjects: 205
Study 22009525 — intervention group
Group type: COMPARATOR
Intervention: Intravenous meropenem (MEM IV) 500 mg b.i.d. in upper gastrointestinal surgery patients.
Number of subjects: 205
Study 19936845 — intervention group
Group type: EXPERIMENTAL
Intervention: Price estimates provided by hospitals
Number of subjects: 353
Study 19936845 — intervention group
Group type: COMPARATOR
Intervention: No response or incomplete information from hospitals
Number of subjects: 353
Study 18611150 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacopa monnieri extract 300 mg/day
Number of subjects: 54
Study 18611150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 18578895 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 130
Study 18578895 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal Therapy (IPT)
Number of subjects: 130
Study 18578895 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy (PHT)
Number of subjects: 130
Study 15730064 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) alone or in combination with cognitive restructuring
Number of subjects: 69
Study 11726307 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride (KCl) containing chewing gum used up to 6 times daily for 10 min each occasion for 3 weeks
Number of subjects: 59
Study 11726307 — intervention group
Group type: COMPARATOR
Intervention: Non-desensitising toothpaste
Number of subjects: 59
Study 9234034 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg methylphenidate (MPH)
Number of subjects: 60
Study 9234034 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy regarding medication
Number of subjects: 60
Study 7685719 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injection of hyperosmolar (50%) glucose solution
Number of subjects: 40
Study 7685719 — intervention group
Group type: COMPARATOR
Intervention: Salpingostomy
Number of subjects: 40
Study 3539128 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopoderm TTS (SCOTTS)
Number of subjects: 20
Study 3539128 — intervention group
Group type: COMPARATOR
Intervention: Dimenhydrinate
Number of subjects: 20
Study 11589870 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with large cup-to-disk ratios and both abnormal standard achromatic automated perimetry and short-wavelength automated perimetry (n = 22)
Number of subjects: 76
Study 11589870 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with large cup-to-disk ratios and both normal standard achromatic automated perimetry and short-wavelength automated perimetry (n = 42)
Number of subjects: 76
Study 11589870 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 76
Study 11589870 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with large cup-to-disk ratios and abnormal short-wavelength automated perimetry only (n = 9)
Number of subjects: 76
Study 30932134 — intervention group
Group type: EXPERIMENTAL
Intervention: 2RDA (2 times the recommended daily allowance of protein intake, 2g/kg/d)
Number of subjects: 26
Study 30932134 — intervention group
Group type: COMPARATOR
Intervention: RDA (current recommended daily allowance of protein intake, 0.8g/kg/d)
Number of subjects: 26
Study 29974946 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary patient care bundle intervention
Number of subjects: 0
Study 26761382 — intervention group
Group type: EXPERIMENTAL
Intervention: HDTBR
Number of subjects: 12
Study 26761382 — intervention group
Group type: EXPERIMENTAL
Intervention: HDTBR (headache episodes)
Number of subjects: 12
Study 24772415 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 65 mg kg(‐1) infusion in 250 mL 5% dextrose at 3.5 mL/min (Group M)
Number of subjects: 40
Study 24772415 — intervention group
Group type: COMPARATOR
Intervention: Control group received saline (Group C)
Number of subjects: 40
Study 24772415 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 65 mg kg(‐1) infusion (Group M)
Number of subjects: 40
Study 23413492 — intervention group
Group type: EXPERIMENTAL
Intervention: HA gauze pad (ialuset gauze pad)
Number of subjects: 170
Study 23413492 — intervention group
Group type: COMPARATOR
Intervention: HC dressing (DuoDERM E)
Number of subjects: 170
Study 20036097 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐min in‐person pain education/communication intervention
Number of subjects: 89
Study 20036097 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 89
Study 18608623 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Weight School therapy program in group meetings
Number of subjects: 72
Study 18608623 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 72
Study 16003654 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard protocol (STD)
Number of subjects: 58
Study 16003654 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency reduction (FRD)
Number of subjects: 58
Study 16003654 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction (WRD)
Number of subjects: 58
Study 16003654 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetition reduction (RRD)
Number of subjects: 58
Study 16003654 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study 12468603 — intervention group
Group type: COMPARATOR
Intervention: Cracker only
Number of subjects: 25
Study 12468603 — intervention group
Group type: COMPARATOR
Intervention: Cracker with cream cheese
Number of subjects: 25
Study 12468603 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral stimulation by fat
Number of subjects: 25
Study 12468603 — intervention group
Group type: EXPERIMENTAL
Intervention: Safflower oil capsules
Number of subjects: 25
Study 10369171 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive Behaviour Therapy (CBT) during hospital rehabilitation
Number of subjects: 59
Study 10369171 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation services during hospitalization
Number of subjects: 59
Study 7547095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenidap sodium (120 mg day‐1)
Number of subjects: 18
Study 7547095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 7547095 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenidap sodium
Number of subjects: 18
Study 2197394 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery Training and Self-help (RTSH)
Number of subjects: 168
Study 7009093 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly A. Poly U I.V. 30 mg per week for 6 weeks
Number of subjects: 300
Study 7009093 — intervention group
Group type: COMPARATOR
Intervention: Normal saline I.V. on the same schedule
Number of subjects: 300
Study 30514652 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Unidas
Number of subjects: 746
Study 30514652 — intervention group
Group type: COMPARATOR
Intervention: Prevention as usual
Number of subjects: 746
Study 28692586 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release metformin
Number of subjects: 20
Study 28692586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 26679879 — intervention group
Group type: EXPERIMENTAL
Intervention: Truview laryngoscope
Number of subjects: 100
Study 26679879 — intervention group
Group type: COMPARATOR
Intervention: McCoy laryngoscope
Number of subjects: 100
Study 24749956 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric tube-guided technique
Number of subjects: 60
Study 24749956 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 60
Study 22723185 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy screening with removal of all detected lesions
Number of subjects: 68400
Study 22723185 — intervention group
Group type: COMPARATOR
Intervention: No screening (standard of care)
Number of subjects: 68400
Study 22166651 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin monotherapy
Number of subjects: 147
Study 22166651 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin plus metformin (0.5 g, tid)
Number of subjects: 147
Study 22166651 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin plus metformin (0.5 g, tid) and pioglitazone (15 mg, qd)
Number of subjects: 147
Study 17828060 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental stabilizing exercises (SSE)
Number of subjects: 100
Study 16219190 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol-fluticasone
Number of subjects: 3421
Study 16219190 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone alone
Number of subjects: 3421
Study 14529880 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac and MMF (n = 41)
Number of subjects: 75
Study 14529880 — intervention group
Group type: COMPARATOR
Intervention: Tac and Aza (n = 34)
Number of subjects: 75
Study 11092645 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT 2 (1 mg 17beta‐estradiol plus 0.025 mg gestodene for 12 days every third month)
Number of subjects: 321
Study 11092645 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT 1 (1 mg 17beta‐estradiol plus 0.025 mg gestodene for 12 days every month)
Number of subjects: 321
Study 11092645 — intervention group
Group type: COMPARATOR
Intervention: No HRT
Number of subjects: 321
Study 8636896 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants expecting to perform a task alone
Number of subjects: 0
Study 8636896 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants expecting to interact with another participant
Number of subjects: 0
Study 8636896 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants anticipating interaction with partners in neutral or good moods
Number of subjects: 0
Study 8636896 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants whose mood was not manipulated
Number of subjects: 0
Study 1592282 — intervention group
Group type: EXPERIMENTAL
Intervention: Two intracavitary radium insertions
Number of subjects: 143
Study 1592282 — intervention group
Group type: COMPARATOR
Intervention: One intracavitary radium insertion
Number of subjects: 143
Study 6370492 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg bid
Number of subjects: 301
Study 6370492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 30516719 — intervention group
Group type: EXPERIMENTAL
Intervention: Right approach
Number of subjects: 150
Study 30516719 — intervention group
Group type: COMPARATOR
Intervention: Left approach
Number of subjects: 150
Study 30516719 — intervention group
Group type: COMPARATOR
Intervention: Bilateral approach
Number of subjects: 150
Study 29370538 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS‐MPH
Number of subjects: 255
Study 29370538 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 255
Study 27171844 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone (0.1 mg/kg twice/day for 12 months)
Number of subjects: 54
Study 27171844 — intervention group
Group type: COMPARATOR
Intervention: Control (no oxandrolone)
Number of subjects: 54
Study 24326527 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (n=24)
Number of subjects: 68
Study 24326527 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=25)
Number of subjects: 68
Study 22459203 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised population of the NELSON trial
Number of subjects: 10627
Study 22459203 — intervention group
Group type: EXPERIMENTAL
Intervention: Respondents of the first questionnaire
Number of subjects: 10627
Study 22459203 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers in the randomised population
Number of subjects: 10627
Study 22459203 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers in the respondents
Number of subjects: 10627
Study 20045873 — intervention group
Group type: EXPERIMENTAL
Intervention: Life review intervention
Number of subjects: 83
Study 20045873 — intervention group
Group type: COMPARATOR
Intervention: Control group (watching a video about the art of growing older)
Number of subjects: 83
Study 20045873 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study 18823213 — intervention group
Group type: EXPERIMENTAL
Intervention: Native speakers of Sinhala
Number of subjects: 3
Study 18823213 — intervention group
Group type: EXPERIMENTAL
Intervention: Native speakers of German
Number of subjects: 3
Study 18823213 — intervention group
Group type: EXPERIMENTAL
Intervention: Native speakers of Dutch
Number of subjects: 3
Study 18823213 — intervention group
Group type: COMPARATOR
Intervention: Perceptual interference
Number of subjects: 3
Study 15917280 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on oral anticoagulation, anticoagulation files, and patient information booklets; Group B received feedback every 2 months; Group C used CoaguChek device; Group D received Dawn AC computer assisted advice
Number of subjects: 66
Study 15917280 — intervention group
Group type: COMPARATOR
Intervention: Education on oral anticoagulation, anticoagulation files, and patient information booklets
Number of subjects: 66
Study 12546514 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid tablets 2.4 g/day and enema 2 g/day for 4 weeks
Number of subjects: 149
Study 12546514 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid tablets 2.4 g/day and enema 2 g/day for 8 weeks
Number of subjects: 149
Study 12546514 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mesalazine alone at 1.2 g/day during maintenance period
Number of subjects: 149
Study 12546514 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminosalicylic acid tablets 2.4 g/day and enema 2 g/day for 8 weeks (specifically for left-sided colitis)
Number of subjects: 149
Study 9849115 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal Breastfeeding Workshops
Number of subjects: 159
Study 9849115 — intervention group
Group type: COMPARATOR
Intervention: Control (non-attendees)
Number of subjects: 159
Study 7985276 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 17
Study 2690913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adriamycin 50 mg, vincristine 1 mg, cyclophosphamide 250 mg, methotrexate 150 mg and fluorouracil 250 mg (AVCMF) every 21 days for eight cycles
Number of subjects: 569
Study 2690913 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 569
Study 1155990 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrachlorethylene (T.C.E.) - single dose
Number of subjects: 0
Study 1155990 — intervention group
Group type: COMPARATOR
Intervention: Bephenium hydroxynaphthoate - single dose
Number of subjects: 0
Study 1155990 — intervention group
Group type: COMPARATOR
Intervention: Pyrantel pamoate - single dose
Number of subjects: 0
Study 1155990 — intervention group
Group type: EXPERIMENTAL
Intervention: Bephenium hydroxynaphthoate - three daily doses
Number of subjects: 0
Study 1155990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrantel pamoate - three daily doses
Number of subjects: 0
Study 31901090 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold analgesic technique
Number of subjects: 100
Study 31901090 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic cream
Number of subjects: 100
Study 31901090 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration analgesic technique
Number of subjects: 100
Study 31901090 — intervention group
Group type: COMPARATOR
Intervention: No-treatment arm (Control)
Number of subjects: 100
Study 30880163 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone implant
Number of subjects: 200
Study 30880163 — intervention group
Group type: COMPARATOR
Intervention: Oral naltrexone placebo
Number of subjects: 200
Study 29283224 — intervention group
Group type: EXPERIMENTAL
Intervention: Autonomic regulation therapy (ART) using right cervical vagus nerve stimulation (VNS)
Number of subjects: 0
Study 29283224 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27421268 — intervention group
Group type: EXPERIMENTAL
Intervention: Promise of a monetary incentive at first mailout
Number of subjects: 1029
Study 27421268 — intervention group
Group type: COMPARATOR
Intervention: Promise on reminder letters only
Number of subjects: 1029
Study 24997819 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal ligament anesthesia using C‐CLADS
Number of subjects: 50
Study 24997819 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual submucosal infiltration anesthesia
Number of subjects: 50
Study 22815970 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based aerobic interval training (AIT)
Number of subjects: 30
Study 22815970 — intervention group
Group type: COMPARATOR
Intervention: Residential rehabilitation
Number of subjects: 30
Study 20615781 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl and propofol (group B)
Number of subjects: 432
Study 20615781 — intervention group
Group type: COMPARATOR
Intervention: Intravenous propofol (group A)
Number of subjects: 432
Study 17572517 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous terbutaline
Number of subjects: 49
Study 17572517 — intervention group
Group type: COMPARATOR
Intervention: Intravenous normal saline (placebo)
Number of subjects: 49
Study 15744630 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 15744630 — intervention group
Group type: COMPARATOR
Intervention: Tricyclic Antidepressants (TCAs)
Number of subjects: 0
Study 15744630 — intervention group
Group type: COMPARATOR
Intervention: Other SSRIs
Number of subjects: 0
Study 15744630 — intervention group
Group type: COMPARATOR
Intervention: TCAs and related ADs
Number of subjects: 0
Study 12137859 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG added urinary perfusion for 5 hours
Number of subjects: 56
Study 12137859 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hCG)
Number of subjects: 56
Study 9457291 — intervention group
Group type: EXPERIMENTAL
Intervention: Puboprostatic ligament‐sparing technique
Number of subjects: 43
Study 7621644 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive finger artery blood pressure (Finapres)
Number of subjects: 13
Study 2524114 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of diflunisal and cyclobenzaprine HCl
Number of subjects: 175
Study 2524114 — intervention group
Group type: COMPARATOR
Intervention: Diflunisal
Number of subjects: 175
Study 2524114 — intervention group
Group type: COMPARATOR
Intervention: Cyclobenzaprine HCl
Number of subjects: 175
Study 2524114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 71492 — intervention group
Group type: EXPERIMENTAL
Intervention: High-potency antilymphocyte globulin (A.L.G.)
Number of subjects: 71
Study 71492 — intervention group
Group type: COMPARATOR
Intervention: Moderate-potency antilymphocyte globulin (A.L.G.)
Number of subjects: 71
Study 6129872 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (2 X 60 mg/day)
Number of subjects: 20
Study 6129872 — intervention group
Group type: COMPARATOR
Intervention: Clemastine (2 X 1 mg/day)
Number of subjects: 20
Study 31626692 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic platelet transfusion
Number of subjects: 372
Study 31626692 — intervention group
Group type: COMPARATOR
Intervention: Control (no transfusion)
Number of subjects: 372
Study 31361307 — intervention group
Group type: EXPERIMENTAL
Intervention: Late parenteral nutrition (PN)
Number of subjects: 1128
Study 31361307 — intervention group
Group type: COMPARATOR
Intervention: Early parenteral nutrition (PN)
Number of subjects: 1128
Study 28222696 — intervention group
Group type: EXPERIMENTAL
Intervention: Transillumination-assisted technique (T group)
Number of subjects: 500
Study 28222696 — intervention group
Group type: COMPARATOR
Intervention: Midline approach technique (R group)
Number of subjects: 500
Study 25912908 — intervention group
Group type: EXPERIMENTAL
Intervention: High Cadence Training (HCT)
Number of subjects: 36
Study 25912908 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Cadence Training (LCT)
Number of subjects: 36
Study 25912908 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 36
Study 23688096 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) with vitamin E supplementation (200 mg every other day)
Number of subjects: 38
Study 23688096 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) without vitamin E supplementation
Number of subjects: 38
Study 23688096 — intervention group
Group type: COMPARATOR
Intervention: Control group (22 systemically and periodontally healthy individuals)
Number of subjects: 38
Study 22412025 — intervention group
Group type: EXPERIMENTAL
Intervention: 400,000 IU of vitamin A
Number of subjects: 276
Study 22412025 — intervention group
Group type: COMPARATOR
Intervention: 200,000 IU of vitamin A
Number of subjects: 276
Study 19901116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib 30 mg/d with antihypertensive prophylaxis
Number of subjects: 126
Study 19901116 — intervention group
Group type: COMPARATOR
Intervention: Cediranib 30 mg/d without antihypertensive prophylaxis
Number of subjects: 126
Study 19901116 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib 45 mg/d with antihypertensive prophylaxis
Number of subjects: 126
Study 19901116 — intervention group
Group type: COMPARATOR
Intervention: Cediranib 45 mg/d without antihypertensive prophylaxis
Number of subjects: 126
Study 19901116 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (cediranib 30 or 45 mg/d with or without antihypertensive prophylaxis)
Number of subjects: 126
Study 17320580 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mL of autologous blood infused in the pleural cavity (Group A)
Number of subjects: 25
Study 17320580 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mL of autologous blood infused in the pleural cavity (Group B)
Number of subjects: 25
Study 17320580 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C) - last 15 patients with air leaks for at least 6 days
Number of subjects: 25
Study 15358853 — intervention group
Group type: EXPERIMENTAL
Intervention: CT angiography
Number of subjects: 145
Study 15358853 — intervention group
Group type: COMPARATOR
Intervention: Digital subtraction angiography (DSA)
Number of subjects: 145
Study 12004696 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized system (the Wand)
Number of subjects: 30